Government of Canada invests $20 million to improve health outcomes of children living with rare diseases
The Government of Canada, through CIHR, is investing $20M in the creation of a national pediatric rare disease clinical trials and treatments network, led by Dr. Thierry Lacaze-Masmonteil and his team.